Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $109M (100.0% shares, 0.0% debt)

Holdings (23)

— Biohaven Pharmactl Hldg Co L 32.7%

Value $35.77M Shares 857,494 Est. Cost $27.10 Unrealized —

— Corbus Pharmaceuticals HLDGS 22.2%

Value $24.28M Shares 4,985,870 Est. Cost $4.98 Unrealized —

— Blackstone Group LP 6.8%

Value $7.473M Shares 153,000 Est. Cost $34.97 Unrealized —

— Abeona Therapeutics Inc 4.9%

Value $5.333M Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Applied Therapeutics Inc 4.7%

Value $5.133M Shares 467,071 Est. Cost $8.24 Unrealized —

KRYS Krystal Biotech Inc 3.8%

Value $4.174M Shares 120,212 Est. Cost $10.08 Unrealized +343.4%

MO Altria Group Inc 3.4%

Value $3.681M Shares 90,000 Est. Cost $29.72 Unrealized -7.1%

— Eiger Biopharmaceuticals Inc 3.3%

Value $3.59M Shares 350,238 Est. Cost $10.44 Unrealized —

KBA Kraneshares TR 2.6%

Value $2.87M Shares 96,000 Est. Cost $31.89 Unrealized —

ALDX Aldeyra Therapeutics Inc 2.6%

Value $2.801M Shares 531,568 Est. Cost $8.55 Unrealized -37.1%

— Centurylink Inc 2.5%

Value $2.746M Shares 220,000 Est. Cost $12.48 Unrealized —

AVXL Anavex Life Sciences Corp 2.1%

Value $2.288M Shares 724,205 Est. Cost $3.56 Unrealized -19.0%

DD Dupont de Nemours Inc 2.0%

Value $2.139M Shares 30,000 Est. Cost $27.24 Unrealized -4.9%

DOW Dow Inc 1.3%

Value $1.43M Shares 30,000 Est. Cost $36.37 Unrealized -10.0%

ENTX Entera Bio Ltd 1.1%

Value $1.184M Shares 475,540 Est. Cost $6.29 Unrealized -53.8%

CTVA Corteva Inc 0.8%

Value $840K Shares 30,000 Est. Cost $25.02 Unrealized +6.6%

— Molecular Templates 0.7%

Value $751K Shares 113,905 Est. Cost $4.04 Unrealized —

— Soligenix Inc. 0.7%

Value $748K Shares 787,830 Est. Cost $2.11 Unrealized —

— Galmed Pharmaceuticals Ltd 0.6%

Value $696K Shares 145,694 Est. Cost $11.90 Unrealized —

— Catasys Inc 0.6%

Value $678K Shares 43,034 Est. Cost $16.93 Unrealized —

— Electrocore Inc 0.4%

Value $481K Shares 219,844 Est. Cost $16.51 Unrealized —

— Lipocine Inc New 0.1%

Value $141K Shares 50,000 Est. Cost $1.30 Unrealized —

— Vascular Biogenics Ltd 0.0%

Value $29,000 Shares 21,400 Est. Cost $1.31 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmactl Hldg Co L	857,494	$35.77M	32.7%	$27.10	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	4,985,870	$24.28M	22.2%	$4.98	—	COM	21833P103
—	Blackstone Group LP	153,000	$7.473M	6.8%	$34.97	—	COM UNIT LTD	09253U108
—	Abeona Therapeutics Inc	2,359,767	$5.333M	4.9%	$4.97	—	COM	00289Y107
—	Applied Therapeutics Inc	467,071	$5.133M	4.7%	$8.24	—	COM	03828A101
KRYS	Krystal Biotech Inc	120,212	$4.174M	3.8%	$10.08	+343.4%	COM	501147102
MO	Altria Group Inc	90,000	$3.681M	3.4%	$29.72	-7.1%	COM	02209S103
—	Eiger Biopharmaceuticals Inc	350,238	$3.59M	3.3%	$10.44	—	COM	28249U105
KBA	Kraneshares TR	96,000	$2.87M	2.6%	$31.89	—	BOSERA MSCI CH	500767405
ALDX	Aldeyra Therapeutics Inc	531,568	$2.801M	2.6%	$8.55	-37.1%	COM	01438T106
—	Centurylink Inc	220,000	$2.746M	2.5%	$12.48	—	COM	156700106
AVXL	Anavex Life Sciences Corp	724,205	$2.288M	2.1%	$3.56	-19.0%	COM NEW	032797300
DD	Dupont de Nemours Inc	30,000	$2.139M	2.0%	$27.24	-4.9%	COM	26614N102
DOW	Dow Inc	30,000	$1.43M	1.3%	$36.37	-10.0%	COM	260557103
ENTX	Entera Bio Ltd	475,540	$1.184M	1.1%	$6.29	-53.8%	SHS	M40527109
CTVA	Corteva Inc	30,000	$840K	0.8%	$25.02	+6.6%	COM	22052L104
—	Molecular Templates	113,905	$751K	0.7%	$4.04	—	COM	608550109
—	Soligenix Inc.	787,830	$748K	0.7%	$2.11	—	COM	834223307
—	Galmed Pharmaceuticals Ltd	145,694	$696K	0.6%	$11.90	—	SHS	M47238106
—	Catasys Inc	43,034	$678K	0.6%	$16.93	—	COM PAR	149049504
—	Electrocore Inc	219,844	$481K	0.4%	$16.51	—	COM	28531P103
—	Lipocine Inc New	50,000	$141K	0.1%	$1.30	—	COM	53630X104
—	Vascular Biogenics Ltd	21,400	$29,000	0.0%	$1.31	—	COM	M96883109